Christina Farr is a technology and health reporter for CNBC.com in San Francisco. She most recently was a senior writer at Fast Company, covering biotech and health-tech for digital and print, and an Apple reporter at Reuters News. She hails from London, UK and is a graduate of Stanford's School of Journalism. Reach her on Twitter (@chrissyfarr).
Amazon has put Google Glass creator Babak Parviz in charge of an ambitious group called Grand Challenge.
Apple is taking the next step in the health records market by giving researchers and app developers access to data.
Alphabet's Verily is adding executives and advisers as it moves to commercialize its research.
23andMe had an option back in 2013 to appease its critics, but it chose to stick with the direct-to-consumer path.
Disruptor 50 start-up Oscar Health told CNBC that it has a strategy in place to make money and improve the health-care experience for members.
Krishna Yeshwant is a venture capitalist and doctor who has a crafty way to think through his health-tech investments.
Venture capitalist and Palantir co-founder Joe Lonsdale is shifting his attention to health care.
Joe Lonsdale, 8VC founding partner and Palantir co-founder, speaks with CNBC’s Christina Farr about the outlook for health care.
The Amazon, Berkshire and J.P. Morgan partnership to find grand health-care solutions remains leaderless.
Kleiner Perkins' latest health-tech investment: A dental insurance start-up.